The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest

Silvia Laura Locatelli, Giuseppa Careddu, G. Inghirami, L. Castagna, P. Sportelli, A. Santoro, C. Carlo-Stella

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{bc60402aa75c4f128877da222c968a76,

title = "The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest",

author = "Locatelli, {Silvia Laura} and Giuseppa Careddu and G. Inghirami and L. Castagna and P. Sportelli and A. Santoro and C. Carlo-Stella",

year = "2016",

month = sep,

day = "2",

doi = "10.1038/leu.2016.224",

language = "English",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - The novel PI3K-δ inhibitor TGR-1202 enhances Brentuximab Vedotin-induced Hodgkin lymphoma cell death via mitotic arrest

AU - Locatelli, Silvia Laura

AU - Careddu, Giuseppa

AU - Inghirami, G.

AU - Castagna, L.

AU - Sportelli, P.

AU - Santoro, A.

AU - Carlo-Stella, C.

PY - 2016/9/2

Y1 - 2016/9/2

UR - http://www.scopus.com/inward/record.url?scp=84984846907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984846907&partnerID=8YFLogxK

U2 - 10.1038/leu.2016.224

DO - 10.1038/leu.2016.224

M3 - Article

AN - SCOPUS:84984846907

JO - Leukemia

JF - Leukemia

SN - 0887-6924

ER -